Erythema Nodosum Leprosum

Also known as: Type 2 lepra reaction / Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)

Drug	Drug Name	Drug Description
DB01041	Thalidomide	A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum.

Drug	Drug Name	Target	Type
DB01041	Thalidomide	Cytochrome P450 2C19	enzyme
DB01041	Thalidomide	Cytochrome P450 2C9	enzyme
DB01041	Thalidomide	Prostaglandin G/H synthase 1	enzyme
DB01041	Thalidomide	Prostaglandin G/H synthase 2	enzyme
DB01041	Thalidomide	Cytochrome P450 3A5	enzyme
DB01041	Thalidomide	DNA	target
DB01041	Thalidomide	Protein cereblon	target
DB01041	Thalidomide	alpha1-acid glycoprotein	target
DB01041	Thalidomide	Cytochrome P450 3A4	enzyme
DB01041	Thalidomide	Cytochrome P450 1A1	enzyme
DB01041	Thalidomide	Cytochrome P450 2B6	enzyme

Drug	Drug Name	Phase	Status	Count
DB16242	Dovramilast	2	Recruiting	1
DB05676	Apremilast	4	Completed	1
DB00563	Methotrexate	Not Available	Recruiting	1
DB00471	Montelukast	Not Available	Unknown Status	1
DB00860	Prednisolone	Not Available	Recruiting	1